Position in NVS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,573,625
+$61,553 QoQ
Shares Held
10,041
+1.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#487
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Berkeley Capital Partners, LLC holds $14,092,981 across 9 Drug Manufacturers - General names. NVS ranks #5 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
12,370 | $3,141,608 | |
| 2 | MRK |
Merck & Co., Inc.
|
17,441 | $2,241,168 | |
| 3 | ABBV |
AbbVie Inc.
|
7,720 | $1,942,660 | |
| 4 | LLY |
ELI LILLY & Co
|
1,361 | $1,632,424 | |
| 5 | NVS |
Novartis AG
This page
|
10,041 | $1,573,625 | |
| 6 | PFE |
Pfizer Inc
|
64,286 | $1,548,006 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,331 | $1,459,572 | |
| 8 | NVO |
Novo Nordisk A S
|
6,115 | $293,153 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,573,625 | 10,041 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,512,072 | 9,899 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $328,682 | 2,384 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $265,072 | 2,067 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $233,186 | 1,927 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $253,839 | 2,277 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $234,322 | 2,408 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $691,960 | 6,016 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,937,997 | 18,204 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,755,842 | 18,152 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $631,971 | 6,259 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $655,672 | 6,437 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $675,693 | 6,696 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,522,876 | 16,553 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,480,731 | 16,322 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,187,428 | 15,622 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,190,774 | 14,087 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,101,876 | 12,557 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $336,234 | 3,844 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $234,136 | 2,863 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $255,289 | 2,798 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $253,533 | 2,966 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $266,575 | 2,823 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $243,314 | 2,798 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $255,382 | 2,924 | Shares | Sole | 2020-07-30 | |
| 2020-03-31 | $249,576 | 3,027 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||